SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-19-178809
Filing Date
2019-06-21
Accepted
2019-06-21 16:19:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d728085d424b3.htm 424B3 250183
2 GRAPHIC g728085g47r41.jpg GRAPHIC 40937
  Complete submission text file 0001193125-19-178809.txt   307678
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: 424B3 | Act: 33 | File No.: 333-232074 | Film No.: 19911749
SIC: 2834 Pharmaceutical Preparations